Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 8-bromo-6-[(4-tert-butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepine | HCID 59618636 | — |
| Reactant | HCID 178418416 | HCID 178418416 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Catalyst | Ferrocene-1,1'-bis-(diphenylphosphine) | HCID 635956 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Product | HCID 66901654 | HCID 66901654 | — |
Reaction Steps
To a solution of 8-bromo-6-[(4-tert-butylphenyl)sulfonyl]-2-(trifluoromethyl)-6,11-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepine (0.168 g, 0.32 mmol, intermediate 53) in DMF (2.0 mL) under nitrogent (balloon) was added palladium acetate (0.072 g, 0.32 mmol), dppf (0.220 g, 0.40 mmol), triethylamine (0.080 g, 0.800 mmol), and methanol (2.0 mL). The nitrogen balloon was replaced with a carbon monoxide balloon and the reaction mixture was stirred at rt for 1 h, and at 80° C. for 15 h. After cooling to rt, the reaction mixture was diluted with EtOAc and filtered through a pad of silica gel. The filtrate was concentrated to dryness and the residue was purified by SiO2 column chromatography eluting with EtOAc in hexanes to provide the title compound. LC/MS: m/e 520.1 (M+H)+. 1H NMR (500 MHz, CDCl3): δ 8.28 (1H, d, J=1.6 Hz), 7.94 (1H, dd, J=8.5, 1.8 Hz), 7.61 (1H, d, J=7.5 Hz), 7.13 (1H, d, J=7.6 Hz), 7.10 (2H, d, J=8.5 Hz), 6.99 (1H, s), 6.92 (2H, d, J=8.4 Hz), 6.80 (1H, m), 4.70-4.90 (2H, br), 3.95 (3H, s), 1.25 (9H, s).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08153626B2 |
|---|
| Source dataset | uspto-grants-2012_04 |
|---|
| ORD ID | ord-cec5c9dffd584e66a417aba83d17a1f8 |
|---|
| Source note | uspto-grants-2012_04 |
|---|